Study of AZD8931 in Patients With Advanced Solid Malignancies
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to explore the safety and tolerability of multiple
ascending doses (MAD) of AZD8931 in patients with advanced solid malignancies